Cargando…
Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079664/ http://dx.doi.org/10.1007/s11102-013-0491-3 |
| _version_ | 1782323886033993728 |
|---|---|
| author | Petersenn, Stephan Farrall, Andrew J. De Block, Christophe Melmed, Shlomo Schopohl, Jochen Caron, Philippe Cuneo, Ross Kleinberg, David Colao, Annamaria Ruffin, Matthieu Hermosillo Reséndiz, Karina Hughes, Gareth Hu, Ke Barkan, Ariel |
| author_facet | Petersenn, Stephan Farrall, Andrew J. De Block, Christophe Melmed, Shlomo Schopohl, Jochen Caron, Philippe Cuneo, Ross Kleinberg, David Colao, Annamaria Ruffin, Matthieu Hermosillo Reséndiz, Karina Hughes, Gareth Hu, Ke Barkan, Ariel |
| author_sort | Petersenn, Stephan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4079664 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40796642014-07-25 Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study Petersenn, Stephan Farrall, Andrew J. De Block, Christophe Melmed, Shlomo Schopohl, Jochen Caron, Philippe Cuneo, Ross Kleinberg, David Colao, Annamaria Ruffin, Matthieu Hermosillo Reséndiz, Karina Hughes, Gareth Hu, Ke Barkan, Ariel Pituitary Erratum Springer US 2013-05-30 2014 /pmc/articles/PMC4079664/ http://dx.doi.org/10.1007/s11102-013-0491-3 Text en © Springer Science+Business Media New York 2013 |
| spellingShingle | Erratum Petersenn, Stephan Farrall, Andrew J. De Block, Christophe Melmed, Shlomo Schopohl, Jochen Caron, Philippe Cuneo, Ross Kleinberg, David Colao, Annamaria Ruffin, Matthieu Hermosillo Reséndiz, Karina Hughes, Gareth Hu, Ke Barkan, Ariel Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study |
| title | Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study |
| title_full | Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study |
| title_fullStr | Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study |
| title_full_unstemmed | Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study |
| title_short | Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study |
| title_sort | erratum to: long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, phase ii extension study |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079664/ http://dx.doi.org/10.1007/s11102-013-0491-3 |
| work_keys_str_mv | AT petersennstephan erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy AT farrallandrewj erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy AT deblockchristophe erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy AT melmedshlomo erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy AT schopohljochen erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy AT caronphilippe erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy AT cuneoross erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy AT kleinbergdavid erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy AT colaoannamaria erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy AT ruffinmatthieu erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy AT hermosilloresendizkarina erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy AT hughesgareth erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy AT huke erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy AT barkanariel erratumtolongtermefficacyandsafetyofsubcutaneouspasireotideinacromegalyresultsfromanopenendedmulticenterphaseiiextensionstudy |